Faculty & Staff bios

Sunil Prabhu, B.Pharm, PhD

Professor of Pharmaceutical Sciences, Executive Associate Dean

College of Pharmacy

E-Mail: sprabhu@westernu.edu

Phone: 909-469-5550


Academic Leadership Certification, Haas School of Business, University of California, Berkeley, 2012

AACP Fellow, Academic Leaders Fellowship Program (ALFP), 2009

Doctor of Philosophy (PhD), Pharmaceutics, 1996
West Virginia University, Morgantown, WV

Bachelor of Pharmacy (B.Pharm)1987
Birla Institute of Technology, India

Research Interest

Formulation development of novel drug delivery systems; application of nanotechnology
for controlled release system design; cancer chemoprevention; targeted therapy.

Research Grant

Principal Investigator, “Combinatorial nanotechnology-based regimens for pancreatic cancer chemoprevention” NIH, National Cancer Institute (NCI), R15 program, 2014-2017.

Principal Investigator, “Chemoprevention of pancreatic cancer using a combinatorial nano-drug system” NIH, National Cancer Institute (NCI), R03 program, 2011-2013.

Principal Investigator, "Combined Chemoprevention Using A Nanotechnology-based Therapeutic System", NIH, National Cancer Institute (NCI), R03 Program, 2007- 2010.


Process and Performance Outcomes of a Nontraditional Postbaccalaureate PharmD Program Geared Toward Internationally Trained Pharmacists.
Authors: Prabhu S, Chung E, Le QA, Nguyen M, Robinson D | Am J Pharm Educ. 2015 Oct 25;79(8):113

Evaluation of ibuprofen loaded solid lipid nanoparticles and its combination regimens for pancreatic cancer chemoprevention.
Authors: Thakkar A, Chenreddy S, Wang J, Prabhu S | Int J Oncol. 2015 Apr;46(4):1827-34

Reverse cardiac remodeling after renal denervation: Atrial electrophysiologic and structural changes associated with blood pressure lowering.
Authors: McLellan AJ, Schlaich MP, Taylor AJ, Prabhu S, Hering D, Hammond L, Marusic P, Duval J, Sata Y, Ellims A, Esler M, Peter K, Shaw J, Walton A, Kalman JM, Kistler PM | Heart Rhythm. 2015 May;12(5):982-90

Peripheral residence of naïve CD4 T cells induces MHC class II-dependent alterations in phenotype and function.
Authors: Rane S, Das R, Ranganathan V, Prabhu S, Das A, Mattoo H, Durdik JM, George A, Rath S, Bal V | BMC Biol. 2014 Dec 21;12:106

Traditional Chinese medicinal formula Si-Wu-Tang prevents oxidative damage by activating Nrf2-mediated detoxifying/antioxidant genes.
Authors: Liu M, Ravula R, Wang Z, Zuo Z, Chow MS, Thakkar A, Prabhu S, Andresen B, Huang Y | Cell Biosci. 2014 Feb 10;4(1):8

The molecular mechanism of action of aspirin, curcumin and sulforaphane combinations in the chemoprevention of pancreatic cancer.
Authors: Thakkar A, Sutaria D, Grandhi BK, Wang J, Prabhu S | Oncol Rep. 2013 Apr;29(4):1671-7

Chemoprevention of colon cancer in a rat carcinogenesis model using a novel nanotechnology-based combined treatment system.
Authors: Chaudhary A, Sutaria D, Huang Y, Wang J, Prabhu S | Cancer Prev Res (Phila). 2011 Oct;4(10):1655-64

Molecular basis of traditional Chinese medicine in cancer chemoprevention.
Authors: Wang S, Penchala S, Prabhu S, Wang J, Huang Y | Curr Drug Discov Technol. 2010 Mar;7(1):67-75

Novel combinations of rate-controlling polymers for the release of leuprolide acetate in the colon.
Authors: Prabhu S, Kanthamneni N, Ma C | Drug Deliv. 2008 Feb;15(2):119-25

Effect of co-solvents on the controlled release of calcitonin polypeptide from in situ biodegradable polymer implants.
Authors: Prabhu S, Tran LP, Betageri GV | Drug Deliv. 2005 Nov-Dec;12(6):393-8